KLK3 and obesity disorder: Less PSA levels may potentially play a role in the “protector” mechanism, not only because it is engaged in lower androgen concentrations, but also because it may be undetectable due to hemodilution produced by recurrent obesity in T2DM (Antunes et al., 2018; Miller et al., 2018).